Heres the realistic timeline: Phase 3 trials (AMAZE program): - AMAZE 1 (obesity) started February 2026, enrolling ~1,150 participants - Primary completion estimated: June 2029 - Phase 3 in T2D also being planned following the ADA 2026 data US FDA approval (projected): Q4 2030 at the earliest (GlobalData estimate) EU EMA approval (projected): Q1 2031 at the earliest Bulgaria and Eastern Europe: Typically 612 months after EMA approval for market access, depending on national reimbursement negotiations
(And youll likely lower your risk of injury since youre not overtaxing tired muscles.) Instead of injecting glutathione independently, have our professional nurses administer our a Glutathione IV to ensure you are receiving top quality glutathione safely
Other treatments include: Radiation Therapy Radiation therapy shrinks tumors that have spread beyond the original site of the melanoma to other areas such as the brain, spinal cord, lungs or bones
The treatment itself takes only a few minutes and can easily be completed during a short office visit
Research shows GHK-Cu affects over 4,000 genes involved in tissue repair, collagen synthesis, and inflammatory regulation
However, a better understanding of the cellular and molecular mechanisms that are involved in the underlying inflammatory and destructive processes has revealed several new targets for which drugs are now in development, and the prospects for finding new treatments are good
